Evidence-Based Complementary and Alternative Medicine / 2014 / Article / Tab 5

Review Article

Aspirin Resistance and Promoting Blood Circulation and Removing Blood Stasis: Current Situation and Prospectives

Table 5

Analysis of platelet aggregation rate induced by ADP.

TrialsMD (95% CI) value

Chinese formula versus anti-platelet-aggregation drugs
 Tong xin luo capsule versus clopidogrel113.32 [7.68, 18.96]<0.00001
 Zhilong huoxue capsule versus aspirin1−5.50 [−10.49, −0.51]0.03
 Di’ao xinxuekang capsule versus aspirin1−5.50 [−10.49, −0.51]0.03

Meta-analysis30.70 [−11.07, 12.48]0.91

Chinese formula plus anti-platelet-aggregation drugs versus anti-platelet-aggregation drugs
 Composite salvia dropping pill plus aspirin versus aspirin1−13.92 [−19.58, −8.26]<0.00001
 Huo xue capsule plus aspirin versus aspirin1−40.97 [−49.64, −32.30]<0.00001
 Tong xin luo capsule plus aspirin versus aspirin1−2.51 [−4.46, −0.56]0.01
 Xinnao shutong capsule plus aspirin versus aspirin1−23.26 [−26.11, −20.41]<0.00001
 Xuefu zhuyu decoction plus aspirin versus aspirin1−16.82 [−22.12, −11.52]<0.00001
 Ginkgo biloba extract plus aspirin versus aspirin1−2.87 [−7.00, 1.26]0.17

Meta-analysis5−17.61 [−19.56, −15.65]<0.00001

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.